Moelis & Company (NYSE:MC) is one of the 12 Most Undervalued Financial Stocks to Buy Now. On March 12, 2026, Moelis & Company (NYSE:MC) saw UBS lower its price target on the shares to $59 from $74 previously while maintaining a Neutral rating.
Last month, Moelis & Company (NYSE:MC) reported Q4 EPS of $1.13, beating the 83c consensus estimate. Revenue came in at $487.9 million compared with the consensus of $435.1 million. CEO Navid Mahmoodzadegan said the firm delivered “strong momentum” in 2025, supported by what Mahmoodzadegan described as the strongest coverage platform in the company’s history, adding that Moelis enters 2026 positioned to drive further growth and long-term value.
Moelis & Company (NYSE:MC) operates as an investment banking advisory firm providing services including mergers and acquisitions, recapitalizations, restructurings, capital markets transactions, strategic advisory, capital structure advisory, and private capital advisory across North and South America, Europe, the Middle East, Asia, and Australia.
While we acknowledge the potential of MC as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock.
READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.
Disclosure: None. Follow Insider Monkey on Google News.
